Johns Hopkins logo

Health Newsfeed

EXEMESTANE

CAN DRUG THERAPY PREVENT BREAST CANCER IN WOMEN AT RISK? ELIZABETH TRACEY REPORTS

Exemestane is one of a class of breast cancer drugs known as aromatase inhibitors. The drug has now been tested in women at risk to develop breast cancer, and Ben Park, a breast cancer expert at Johns Hopkins, says the data show a benefit.

PARK: They did suggest that you could have the protective benefits of hormone therapy by taking exemestane and that some of the known side effects that we have with tamoxifen could be either completely eliminated or greatly reduced. That doesn’t mean however that these drugs are completely benign. For those women who have taken exemestane and other aromatase inhibitors they know that there are a whole host of side effects that are associated with aromatase inhibitors that in some cases may even preclude women from taking them as well.       :29

Park says exemestane has already been shown to benefit women who already have breast cancer, but that women at risk often don’t choose to take medications because of the side effects. At Johns Hopkins, I’m Elizabeth Tracey.

Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home